Polycystic Ovary Syndrome- Effect of Letrozole and Chinese Herbal Compound
N/A
18 Years
40 Years
18 Years
40 Years
Open (Enrolling)
Female
Polycystic Ovary Syndrome
Female
Polycystic Ovary Syndrome
Trial Information
Polycystic Ovary Syndrome- Effect of Letrozole and Chinese Herbal Compound
Inclusion Criteria:
- Clinical diagnosis of Polycystic ovary syndrome (using 2003 Rotterdam criteria)
- WIth desire for children
Exclusion Criteria:
- Tubal or male factor infertility or sub-fertility
- Suspected peritoneal factor infertility
- Neoplastic, metabolic, hepatic, and cardiovascular disorders or other concurrent
medical illnesses
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
Live birth rate
Outcome Time Frame:
Up to 2 years
Safety Issue:
No
Authority:
China: Ministry of Science and Technology
Study ID:
Letrozole
NCT ID:
NCT01431352
Start Date:
September 2011
Completion Date:
December 2013
Related Keywords:
- Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome
Name | Location |
|---|
